Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Onyx
 More »

  • The 20 Top Paid Women Executives in Biopharma
    ... 2011 Compensation: N/A 3 % Change: N/A 3 #15. Suzanne M. Shema, J.D. Company: Onyx Pharmaceuticals Title: EVP, General Counsel and Corporate Secretary 2012 Compensation: ...
    8-5-2013
  • Novo Nordisk Tops GEN List of Top 25 Biotech Companies
    Isis Pharmaceuticals (NASDAQ:ISIS), Onyx Pharmaceuticals (NASDAQ:ONXX), Vertex Pharmaceuticals (NASDAQ:VRTX), and especially Gilead, which nearly tripled its market cap. ...
    7-25-2013
  • Top 25 Biotech Companies of 2013
    ... shares * price Rs. 1764.75 on 3/30) 1,2 % Change: 0.3% Position on 2012 List: #17 #17. Onyx Pharmaceuticals 2013 Market Cap: $6.580 billion (5/3: 72,738,263 shares * price $90.46) ...
    7-15-2013
  • Onyx Spurns Amgen Offer, Pursues Its Own Deal
    Onyx Pharmaceuticals said yesterday it has begun shopping for its own would-be buyer ... exploring the potential to combine Onyx with another company as an option to ...
    7-1-2013
  • Onyx, UCSF Forge Cancer Innovation Alliance
    Onyx Pharmaceuticals is teaming up with the University of California, San Francisco (UCSF) ... science and medicine at both UCSF and Onyx to address the full continuum of that care ...
    6-3-2013
  • Merck, BMS Immunotherapy Data Whets Clinical Oncology Appetite...
    Meantime, Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals said their Nexavar® (sorafenib) improved median progression-free survival in patients with locally advanced or ...
    6-3-2013
  • GEN | Biolinks
    ... OncoMed Pharmaceuticals, Inc Onconova Therapeutics, Inc OneWorld Health (PATH affiliate) Onyx Pharmaceuticals, Inc Opexa Therapeutics OPX Biotechnologies, Inc. Oregon Bioscience ...
  • Top 20 Best-Selling Drugs Approved and Launched During 2012
    ... 12,13 Marketer(s): Bayer HealthCare and Onyx Pharmaceuticals Indication(s): Metastatic ... 2012 sales: $64 million Marketer(s): Onyx Pharmaceuticals Indication(s): Multiple ...
    4-4-2013
  • Scaling Up Peptide Drugs
    anemia due to chronic kidney disease in adults on dialysis; Kyprolis(tm) (carfilzomib, Onyx Pharmaceuticals) a proteasome inhibitor to treat multiple myeloma; Gattex (teduglutide, ...
    4-1-2013
  • People in the News
    Previously, he was managing sales and business development at Zymark. He was also managing director of Caliper LS. Adam Moorhouse joined Onyx as a director of business ...
    4-1-2013
  • FDA Blocks Novo, Boosts Celgene
    ... Pomalyst is the second MM drug approved by FDA in the past year. In July, the agency approved Onyx Pharmaceuticals' Kyprolis (carfilzomib). Both drugs were reviewed through FDA's ...
    2-11-2013
  • People in the News
    ... Prior to joining Sepracor, he was the svp and head of the cardiovascular business unit at Novartis Pharmaceuticals. Onyx Pharmaceuticals named N. Anthony Coles, M.D. , as chairman ...
    1-15-2013
  • Virotherapy as a Key to Cancer Treatment
    There have been multiple engineered versions of this virus in clinical trials, including Onyx-015 and H101. The latter has been approved in China and is sold by Shanghai Sunway ...
    1-2-2013
  • Top 20 Venture Capital Firms
    ... Navigenics, Neurocrine Biosciences, Nexus Dx, Nodality, NovaDigm Therapeutics, Novavax, Onyx Pharmaceuticals, Orexigen, Pacific Biosciences, Pharmacopeia, Pharmacyclics, Tesaro, ...
    12-17-2012
  • Biotech: A Model of Creative Acquisition
    ... in 2011. The next three largest U.S. public biopharmaceutical companies-Regeneron, Onyx, and Dendreon-reported total revenues over $1.2 billion in 2011, increasing 1,700% from ...
    12-1-2012

  • Journal Articles

  • Lister Vaccine Strain of Vaccinia Virus Armed with the Endostatin...
    James R Tysome, Pengju Wang, Ghassan Alusi, Arnaud Briat, Rathi Gangeswaran, Jiwei Wang, Vipul Bhakta, Istvan Fodor, Nick R. Lemoine, Yaohe Wang
    Human Gene Therapy and Part B: Methods
    An Oncolytic Virus Superior to dl 1520 (ONYX-015) for Human Head and Neck Cancer Human ... with dl1520 (ONYX-015) the most widely used oncolytic adenovirus in clinical trials. ...
  • Successful Uterine Artery Embolization for Intractable Postpartum...
    Maria I. Pardo, Maria V. Trujillo, Silvia Campos, Verónica Lázaro, Giselle Romero, Alexandra Banguero, Jose Manuel Pumar, María V Trujillo
    Journal of Gynecologic Surgery
    Hemorrhage Using a Novel Embolic Agent: ONYX Journal of Gynecologic Surgery Abstract ... As standard procedures had failed to achieve full hemostasis, a new embolic agent "Onyx" ...
  • Potent Antitumor Activity of Oncolytic Adenovirus Expressing...
    Lili Zhao, Jinfa Gu, Aiwen Dong, Yanhong Zhang, Liu Zhong, Lingfeng He, Yigang Wang, Jinhe Zhang, Zilai Zhang, Jin Huiwang, Qijun Qian, Cheng Qian, Xinyuan Liu
    Human Gene Therapy and Part B: Methods
    tumors with ZD55-IL-24 showed much stronger antitumor activity than that induced by ONYX-015 or Ad-IL- 24. These data indicated that oncolytic adenovirus expressing IL-24 could ...
  • Human Telomerase Reverse Transcriptase Promoter-Driven Oncolytic...
    Joshua C. Doloff, David J. Waxman, Youssef Jounaidi
    Human Gene Therapy and Part B: Methods
    E3B-region-deleted oncolytic adenovirus ONYX-015. Tumor cells infected with ... apoptotic index than cells infected with ONYX-015. Despite the increase in virus-induced ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll